Caffeic Acid Phenethyl Ester Protects Kidneys against Acetylsalicylic Acid Toxicity in Rats

被引:7
作者
Bozkurt, Yasar [1 ]
Bozkurt, Mehtap [2 ]
Turkcu, Gul [3 ]
Sancaktutar, Ahmet Ali [1 ]
Soylemez, Haluk [1 ]
Penbegul, Necmettin [1 ]
Atar, Murat [1 ]
Bodakci, Mehmet Nuri [1 ]
Hatipoglu, Namik Kemal [1 ]
Yuksel, Hatice [4 ]
Kibrisli, Erkan [5 ]
Yavuz, Celal [6 ]
机构
[1] Dicle Univ, Dept Urol, Fac Med, Diyarbakir, Turkey
[2] Dicle Univ, Dept Phys Med & Rehabil, Fac Med, Diyarbakir, Turkey
[3] Dicle Univ, Dept Pathol, Fac Med, Diyarbakir, Turkey
[4] Dicle Univ, Dept Biochem, Fac Med, Diyarbakir, Turkey
[5] Dicle Univ, Dept Family Phys, Fac Med, Diyarbakir, Turkey
[6] Dicle Univ, Dept Cardiovasc Surg, Fac Med, Diyarbakir, Turkey
关键词
caffeic acid phenethyl ester; acetylsalicylic acid; kidney; rats; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; MOUSE SKIN; CELLS; CAPE; POPULATION; APOPTOSIS; PROPOLIS; ASPIRIN;
D O I
10.3109/0886022X.2012.717485
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aim of this study was to investigate the protective effect of caffeic acid phenethyl ester (CAPE) on acetylsalicylic acid (ASA)-induced renal damage in rats. Materials and methods: A total of 40 rats were randomly divided into five groups, with eight rats in each group-group 1: control, not receiving any medication; group 2: ASA (50 mg/kg/day); group 3: ASA (50 mg/kg/day) + CAPE (20 mu g/kg/day); group 4: ASA (100 mg/kg/day); and group 5: ASA (100 mg/kg/day) + CAPE (20 mu g/kg/day). ASA and CAPE were given via orogastric gavage for 5 days. The total oxidant status (TOS), total antioxidant capacity (TAC), and paraoxonase-1 (PON-1) activity of the blood samples and kidney tissues were determined. Histopathological examinations of the kidneys were performed using light microscopic methods. Results: The TOS level in the serum of rats and kidney tissues given ASA (groups 2 and 4) significantly increased, but the levels of TAC and PON-1 in these tissues significantly decreased in group 4 when compared with the control rats (p < 0.05). The levels of TAC and PON-1 in the kidney tissues increased and the levels of TOS decreased in the CAPE treatment groups (groups 3 and 5) when compared with the rats in the no CAPE treatment groups (groups 2 and 4). The PON-1, TAC, and TOS values reverted to normal levels in group 5 when compared to group 4 (p < 0.05). These results were supported by histopathological observation. Conclusion: Oxidative stress plays an important role in ASA-induced nephrotoxicity, and CAPE may protect against ASA-induced nephrotoxicity in rats.
引用
收藏
页码:1150 / 1155
页数:6
相关论文
共 28 条
[1]   Does aspirin acetylate multiple cellular proteins? (Review) [J].
Alfonso, Lloyd F. ;
Srivenugopal, Kalkunte S. ;
Bhat, G. Jayarama .
MOLECULAR MEDICINE REPORTS, 2009, 2 (04) :533-537
[2]   The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells [J].
Chen, YJ ;
Shiao, MS ;
Wang, SY .
ANTI-CANCER DRUGS, 2001, 12 (02) :143-149
[3]  
ECKERSON HW, 1983, AM J HUM GENET, V35, P214
[4]   The effects of caffeic acid phenethyl ester (CAPE) on TNBS-induced colitis in ovariectomized rats [J].
Ek, Rauf Onur ;
Serter, Mukadder ;
Ergin, Kemal ;
Yildiz, Yuksel ;
Cecen, Serpil ;
Kavak, Tulay ;
Yenisey, Cigdem .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (06) :1609-1617
[5]   A novel automated method to measure total antioxidant response against potent free radical reactions [J].
Erel, O .
CLINICAL BIOCHEMISTRY, 2004, 37 (02) :112-119
[6]   A new automated colorimetric method for measuring total oxidant status [J].
Erel, O .
CLINICAL BIOCHEMISTRY, 2005, 38 (12) :1103-1111
[7]  
FRENKEL K, 1993, CANCER RES, V53, P1255
[8]   Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells [J].
Huang, MT ;
Ma, W ;
Yen, P ;
Xie, JG ;
Han, JK ;
Frenkel, K ;
Grunberger, D ;
Conney, AH .
CARCINOGENESIS, 1996, 17 (04) :761-765
[9]   Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population [J].
Huerta, C ;
Castellsague, J ;
Varas-Lorenzo, C ;
Rodríguez, LAG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (03) :531-539
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265